Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension

Hypertension

Volumn 31, Issue 6, 1998, Pages 1255-1260

  Ichihara, Atsuhiro ^a   Imig, John D ^a   Inscho, Edward W ^a   Navar, L Gabriel ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Arterioles; Kidney; Nitric oxide; Rats

Indexed keywords

ANGIOTENSIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; JUXTAGLOMERULAR APPARATUS; KIDNEY BLOOD FLOW; MALE; MICROCIRCULATION; NEPHRON; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION;

EID: 0031840663     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.6.1255     Document Type: Article

References (28)

1. VonThun AM, Van RC, El-Dahr SS, Navar LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol. 1994;266:F120-F128.
2. Ichihara A, Inscho EW, Imig JD, Michel RE, Navar LG. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Hypertension. 1997;29:442-449.
3. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension. 1991;17:707-719.
4. Himmelstein SI, Klotman PE. The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats. Am J Physiol. 1989;257: F190-F196.
5. Wang C, Zou L, Navar LG. Renal response to AT1 blockade in angiotensin II-induced hypertensive rats. J Am Soc Nephrol. 1997;8:535-542.
6. Wang DH, Du Y, Yao A, Hu Z. Regulation of type 1 angiotensin II receptor and its subtype gene expression in kidney by sodium loading and angiotensin II infusion. J Hypertens. 1996;14:1409-1415.
7. Sigmon DH, Beierwaltes WH. Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension. 1993;22: 237-242.
8. Beierwaltes WH, Potter DL, Carretero OA, Sigmon DH. Nitric oxide synthesis inhibition blocks reversal of two-kidney, one clip renovascular hypertension after unclipping. Hypertension. 1995;25:174-179.
9. Deng X, Welch WJ, Wilcox CS. Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension. 1996;27:1173-1179.
10. Ikenaga H, Fallet RW, Carmines PK. Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney. Am J Physiol. 1996;271:F365-F373.
11. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536.
12. Casellas D, Navar LG. In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol. 1984;246:F349-F358.
13. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANGII. Am J Physiol. 1989; 256:F1015-F1020.
14. Ohishi K, Carmines PK, Inscho EW, Navar LG. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol. 1992;263:F900-F906.
15. Ichihara A, Inscho EW, Navar LG. Influence of nitric oxide levels on afferent arteriolar responses to angiotensin II. J Am Soc Nephrol. 1996; 7:1563. Abstract.
16. Ichihara A, Inscho EW, Imig JD, Navar LG. Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol. 1998. In press.
17. Rapaport R. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphoinositide hydrolysis in rat aorta. Circ Res. 1986;18:407-410.
18. Lang D, Lewis MJ. Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta. J Physiol. 1989;411:45-52.
19. Hirata M, Kohse KP, Chang C, Tkebe T, Murad F. Mechanisms of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem. 1990;265: 1268-1273.
20. Kannan MS, Prakash YS, Johnson DE, Sieck GC. Nitric oxide inhibits calcium release from sarcoplasmic reticulum of porcine tracheal smooth muscle cells. Am J Physiol. 1997;272:L1-L7.
21. Yuan X, Bright RT, Aldinger M, Rubin LJ. Nitric oxide inhibits serotonin-induced calcium release in pulmonary artery smooth muscle cells. Am J Physiol. 1997;272:L44-L50.
22. 2+ from intracellular stores. Hypertension. 1997;29:222-227.
23. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 1990;346:69-71.
24. Alonso-Galicia M, Drummond HA, Reddy KK, Falck JR, Roman RJ. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension. 1997;29:320-325.
25. Ma Y, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res. 1993; 72:126-136.
26. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in the renal microcirculation. Am J Physiol. 1996;270:R217-R227.
27. 2+-activated K+ channel in renal arterioles. Am J Physiol. 1996;270: R228-R237.
28. Imig JD, Deichmann PC. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways. Am J Physiol. 1997;273:F274-F282.